The types of medication supplied by Calibrate have been proven to deliver positive weight loss results across several trials. When combined with sustainable physiological change, like with Calibrate, clinically-reviewed results have demonstrated that patients are able to both meet and sustain their weight-loss goals – an impressive feat considering that 95% of traditional diets fail.

It is worth noting that weight-loss medications like those supplied by Calibrate, though displaying positive results thus far, have not undergone the extensive trialling required to confidently state they are safe and effective for long-term use - which does present issues as once on them, patients must continue to take the drugs to avoid regaining the lost weight.

That said, with Calibrate boasting over 20,000 people helped, and patients sustaining health outcomes beyond their first year, its programs are certainly effective, and it remains one to watch as the space evolves. The company has seen good funding in the past, and benefited from the wider buzz around next-gen weight-loss drugs, though it has also seen some negative press surrounding a round of layoffs that was announced over zoom.